Concord Medical Price To Book vs. EBITDA
| CCM Stock | USD 5.09 0.16 3.25% |
For Concord Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Concord Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Concord Medical Services utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Concord Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Concord Medical Services over time as well as its relative position and ranking within its peers.
Concord |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.97) | Revenue Per Share 107.978 | Quarterly Revenue Growth (0.23) | Return On Assets (0.04) | Return On Equity (0.32) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Concord Medical Services EBITDA vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Concord Medical's current stock value. Our valuation model uses many indicators to compare Concord Medical value to that of its competitors to determine the firm's financial worth. Concord Medical Services is rated below average in price to book category among its peers. It is rated below average in ebitda category among its peers . Concord Medical reported last year EBITDA of (261.47 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Concord Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Concord EBITDA vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Concord Medical |
| = | 3.00 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Concord Medical |
| = | (261.47 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Concord EBITDA Comparison
Concord Medical is currently under evaluation in ebitda category among its peers.
Concord Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Concord Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Concord Medical will eventually generate negative long term returns. The profitability progress is the general direction of Concord Medical's change in net profit over the period of time. It can combine multiple indicators of Concord Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -65.4 M | -62.1 M | |
| Income Tax Expense | -24.6 M | -23.3 M | |
| Operating Income | -463 M | -439.8 M | |
| Income Before Tax | -555.6 M | -527.8 M | |
| Total Other Income Expense Net | -92.6 M | -88 M | |
| Net Loss | -440.7 M | -418.7 M | |
| Net Loss | -531 M | -504.5 M | |
| Net Loss | -531 M | -504.5 M | |
| Interest Income | 10.8 M | 18.1 M | |
| Net Interest Income | -154.8 M | -147.1 M | |
| Change To Netincome | 40.4 M | 31.6 M | |
| Net Loss | (68.14) | (71.54) | |
| Income Quality | 0.52 | 0.49 | |
| Net Income Per E B T | 0.54 | 0.51 |
Concord Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Concord Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Concord Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Concord Medical's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Concord Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Use Investing Themes to Complement your Concord Medical position
In addition to having Concord Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Thematic Idea Now
Obamacare
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
To fully project Concord Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Concord Medical Services at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Concord Medical's income statement, its balance sheet, and the statement of cash flows.